Hudson Institute of Medical Research

Site

RNAte Technology Platform

Accreditation No.

21660

Site No.

25860

Date of Accreditation

15 Sep 2025

Address

27-31 Wright St
Clayton, VIC 3168
Australia

hudson.org.au

Contact

Dr Tony Cardno P: +61 (03) 85722459

Availability

Services available to external clients

Scope of Accreditation

RNAte Technology Platform

ISO/IEC 17025 (2017)

Healthcare, Pharmaceutical and Media Products

Service Product Determinant Technique
Analysis in support of clinical trials and/or pre-clinical studies Human biological samples; Synthetic RNA vaccines and therapeutics Quantitation of cytokines/chemokines Cell-based immunoassay; Enzyme linked immunosorbent assay (ELISA); Flow cytometry - Multiplex bead array assay

Capability

Projects are managed in accordance with the GCLP Principles interpreted for research.
Analysis in support of research Human biological samples Impact of pharmaceuticals, biological agents and vaccines on disease and treatment outcomes Isolation and cryopreservation of mononuclear cells (PBMC), plasma and serum; PCR - Quantitative (qPCR)

Capability

Projects are managed in accordance with the GCLP Principles interpreted for research.

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.